Immunogenicity of a bivalent killed thimerosal-free oral cholera vaccine, Euvichol, in an animal model

PURPOSE: An oral cholera vaccine (OCV), Euvichol, with thimerosal (TM) as preservative, was prequalified by the World Health Organization (WHO) in 2015. In recent years, public health services and regulatory bodies recommended to eliminate TM in vaccines due to theoretical safety concerns. In this s...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Eun Young, Lee, Sena, Rho, Semi, Kim, Jae-Ouk, Choi, Seuk Keun, Lee, Young Jin, Park, Joo Young, Song, Manki, Yang, Jae Seung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Vaccine Society 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082675/
https://www.ncbi.nlm.nih.gov/pubmed/30112349
http://dx.doi.org/10.7774/cevr.2018.7.2.104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082675/
https://www.ncbi.nlm.nih.gov/pubmed/30112349
http://dx.doi.org/10.7774/cevr.2018.7.2.104

Ejemplares similares